Michael P. Whyte, MD’s Journal of Clinical Endocrinology and Metabolism (JCEM) manuscript entitled Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia is one of twelve that have been selected for a speaker slot in this year’s “Best of JCEM 2016” oral session to be held at ENDO 2017 in Orlando during the morning of 3 April 2017.
Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.
Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson DD, Bishop N, Hofmann C.
J Clin Endocrinol Metab. 2016 Jan;101(1):334-42. doi: 10.1210/jc.2015-3462.